Differential role of NF-κB, ERK1/2 and AP-1 in modulating the immunoregulatory functions of bone marrow-derived dendritic cells from NOD mice

Cellular Immunology

Volumn 272, Issue 2, 2012, Pages 259-268

  Guindi, Chantal ^a   Ménard, Michaël ^a   Cloutier, Alexandre ^a   Gaudreau, Simon ^a   Besin, Gilles ^a   Larivée, Pierre ^a   McDonald, Patrick P ^a   Dupuis, Gilles ^a   Amrani, Abdelaziz ^a  

^a Centre Hospitalier Universitaire de Sherbrooke   (Canada)

Author keywords

Cytokines; Dendritic cells; Tolerogenic; Type 1 diabetes

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P35; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P52; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELLS; DNA-BINDING PROTEINS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED NOD; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PHENOTYPE; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

MUS;

EID: 83955162368     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.10.005     Document Type: Article

References (46)

1. Lanzavecchia A., Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001, 13:291-298.
2. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity. Trends Immunol 2002, 23:445-449.
3. Besin G., Gaudreau S., Menard M., Guindi C., Dupuis G., Amrani A. TSLP and TSLP-conditioned dendritic cells induce Treg differentiation and protection of NOD mice against diabetes. Diabetes 2008.
4. Gaudreau S., Guindi C., Menard M., Besin G., Dupuis G., Amrani A. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J Immunol 2007, 179:3638-3647.
5. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001, 166:4312-4318.
6. De Smedt T., Van Mechelen M., De Becker G., Urbain J., Leo O., Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997, 27:1229-1235.
7. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997, 159:4772-4780.
8. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001, 194:769-779.
9. Verginis P., Li H.S., Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J Immunol 2005, 174:7433-7439.
10. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., Tizard R., Cate R., Lo D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536.
11. Ouaaz F., Arron J., Zheng Y., Choi Y., Beg A.A. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002, 16:257-270.
12. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998, 188:2175-2180.
13. Wu L., D'Amico A., Winkel K.D., Suter M., Lo D., Shortman K. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998, 9:839-847.
14. Loscher C.E., Draper E., Leavy O., Kelleher D., Mills K.H., Roche H.M. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 2005, 175:4990-4998.
15. Puig-Kroger A., Relloso M., Fernandez-Capetillo O., Zubiaga A., Silva A., Bernabeu C., Corbi A.L. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001, 98:2175-2182.
16. Xiao G., Rabson A.B., Young W., Qing G., Qu Z. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006, 17:281-293.
17. Beinke S., Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004, 382:393-409.
18. Li M., Zhang X., Zheng X., Lian D., Zhang Z.X., Ge W., Yang J., Vladau C., Suzuki M., Chen D., Zhong R., Garcia B., Jevnikar A.M., Min W.P. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 2007, 178:5480-5487.
19. Martin E., O'Sullivan B., Low P. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003, 18:155-167.
20. Agrawal A., Dillon S., Denning T.L., Pulendran B. ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J Immunol 2006, 176:5788-5796.
21. Qian C., Jiang X., An H., Yu Y., Guo Z., Liu S., Xu H., Cao X. LR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 2006, 108:2307-2315.
22. Sato K., Nagayama H., Tadokoro K., Juji T., Takahashi T.A. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J Immunol 1999, 162:3865-3872.
23. Escors D., Lopes L., Lin R., Hiscott J., Akira S., Davis R.J., Collins M.K. Targeting dendritic cell signaling to regulate the response to immunization. Blood 2008, 111:3050-3061.
24. Mollah Z.U., Pai S., Moore C., O'Sullivan B.J., Harrison M.J., Peng J., Phillips K., Prins J.B., Cardinal J., Thomas R. Abnormal NF-{kappa}B function characterizes human Type 1 diabetes dendritic cells and monocytes. J Immunol 2008, 180:3166-3175.
25. Serreze D.V., Gaskins H.R., Leiter E.H. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993, 150:2534-2543.
26. Feili-Hariri M., Morel P.A. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin Immunol 2001, 98:133-142.
27. Poligone B., Weaver D.J., Sen P., Baldwin A.S., Tisch R. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J Immunol 2002, 168:188-196.
28. Weaver D.J., Poligone B., Bui T., Abdel-Motal U.M., Baldwin A.S., Tisch R. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. J Immunol 2001, 167:1461-1468.
29. Wheat W., Kupfer R., Gutches D.G., Rayat G.R., Beilke J., Scheinman R.I., Wegmann D.R. Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 2004, 34:1395-1404.
30. Inaba K., Inaba M., Naito M., Steinman R.M. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993, 178:479-488.
31. Thompson C., Cloutier A., Bosse Y., Poisson C., Larivee P., McDonald P.P., Stankova J. Signaling by the cysteinyl-leukotriene receptor 2. Involvement in chemokine gene transcription. J Biol Chem 2008, 283:1974-1984.
32. Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004, 172:4733-4743.
33. Jansen A., van Hagen M., Drexhage H.A. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995, 345:491-492.
34. Takahashi K., Honeyman M.C., Harrison L.C. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol 1998, 161:2629-2635.
35. Berger T.G., Schulze-Koops H., Schafer M., Muller E., Lutz M.B. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS One 2009, 4:e6645.
36. Berzins S.P., Venanzi E.S., Benoist C., Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes 2003, 52:327-334.
37. You S., Belghith M., Cobbold S., Alyanakian M.A., Gouarin C., Barriot S., Garcia C., Waldmann H., Bach J.F., Chatenoud L. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 2005, 54:1415-1422.
38. Morin J., Faideau B., Gagnerault M.C., Lepault F., Boitard C., Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol 2003, 134:388-395.
39. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000, 30:1813-1822.
40. Gaudreau S., Guindi C., Menard M., Benabdallah A., Dupuis G. GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes. Cell Immunol 2010, 265:31-36.
41. Yi A.K., Yoon J.G., Yeo S.J., Hong S.C., English B.K., Krieg A.M., IL-10 Role of mitogen-activated protein kinases in CpG DNA-mediated, response IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J Immunol 2002, 168:4711-4720.
42. Wang Z.Y., Sato H., Kusam S., Sehra S., Toney L.M., Dent A.L. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J Immunol 2005, 174:2098-2105.
43. Yanagawa Y., Onoe K. Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells. Immunology 2006, 117:526-535.
44. Liou H.C., Sha W.C., Scott M.L., Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 1994, 14:5349-5359.
45. Saccani S., Pantano S., Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 2003, 11:1563-1574.
46. Koga K., Takaesu G., Yoshida R., Nakaya M., Kobayashi T., Kinjyo I., Yoshimura A. yclic Adenosine Monophosphate Suppresses the Transcription of Proinflammatory Cytokines via the Phosphorylated c-Fos Protein. Immunity 2009.